For example, Nguyen et al. loaded cathepsin K inhibitor odanacatib into poly(lactic-co-glycolic) nanoparticles conjugated to TRAIL fusion protein for targeting TRAIL-resistant cancer [55]. This evidence concerns the gene CTSK and cancer.